|  | Hazard ratio (95% CI) | P value | Maximum (97.5th percentile) IPWc | Post-IPW c-indexd | Complete case (%)e | Observed data points (%)f |
---|---|---|---|---|---|---|---|
Total cohort N = 1017 | Unadjusted | 0.27 (0.10–0.76) | 0.01 | – | – | 100 | 100 |
Adjusted for clinical factorsa | 0.19 (0.06–0.60) | 0.005 | 5.4 (4.4) | 0.48 | 88 | 98 | |
Adjusted for clinical & histological factorsb | 0.20 (0.06–0.67) | 0.009 | 7.1 (4.4) | 0.50 | 18 | 88 | |
LN negative patients N = 933 | Unadjusted | 0.25 (0.08–0.83) | 0.02 | – | – | 100 | 100 |
Adjusted for clinical factorsa | 0.21 (0.06–0.77) | 0.02 | 5.6 (4.5) | 0.48 | 88 | 98 | |
Adjusted for clinical & histological factorsb | 0.23 (0.06–0.81) | 0.02 | 7.1 (4.5) | 0.49 | 17 | 87 |